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Multilocus Tests and Interactions, by Chatterjee et
al. (p. 1002)
When looking for an association between genetic variants
and disease, investigators often use multilocus tests to ex-
ploit the fact that several SNPs may be associated or may
be in linkage disequilibrium with a causal variant. The
effects of these variants can be complicated by interactions
with SNPs in other genes or with environmental factors.
Allowances for all these interactions can signiﬁcantly re-
duce power because of the degrees of freedom needed for
the calculations. In an effort to reduce the degrees of free-
dom, Chatterjee et al. propose that, under the assumption
that the multiple SNPs within a gene are related to one
another because of a common causal mechanism, Tukey’s
1-df model for interaction can be used. This allows the
test to account for main effects as well as gene-gene inter-
actions and gene-environment interactions without loss
of too much power. The power of the new method, Tuk-
Assoc, was compared with a method that measured only
main effects and a method that included a saturated in-
teraction analysis. Depending on the model of the joint
effects in the simulations, TukAssoc either had the high-
est power or had power close to that of the main-effects
method. The algorithms were then evaluated using data
from an association study of colorectal adenoma, NAT2
SNPs, and cigarette smoke.When an interactionwith smok-
ing was accounted for, the evidence of association was
strongest when TukAssoc was used.
Biochemical and Genetic Analysis of ANK, by
Gurley et al. (p. 1017)
Familial chondrocalcinosis (CCAL2), the deposition of cal-
cium pyrophosphate dehydrate in the joints, is caused by
mutations in the gene encoding ANKH, a transmembrane
protein believed to be a pyrophosphate transporter. A con-
trasting disease, craniometaphyseal dysplasia (CMD), in
which patients do not have any joint problems but instead
have an abnormal skull and long-bone phenotype, is also
caused by mutations in ANKH. Previous work has sought
to determine the effect that the disease-causingmutations
have on the function of the transporter protein, but results
have been conﬂicting. Here, Gurley et al. used a Xenopus
oocyte system to more directly measure the pyrophosphate
transport activity of wild-type ANKH, ANKH with CCAL2
mutations, andANKHwithCMDmutations. Theyobserved
that, whereas transport levels were similar between the
wild-type proteins and thosewithCCAL2mutations,ANKH
with CMD mutations had very little activity and had a
dominant negative effect on wild-type protein activity.
The effects of the mutations were also evaluated by mea-
suring howwell BACs containing the different diseasemu-
tations could rescue the phenotype of Ank-deﬁcient mice.
Rescue was observed with the wild-type BAC and with the
BAC containing the CCAL2 mutation, but no rescue was
seen with the CMD mutation–containing BAC. The differ-
ent phenotypes caused by the mutations in the same gene
can now be predicted on the basis of how the mutations
affect the function of the protein-transport activity.
Mutations of TRIC Cause DFNB49, by Riazuddin et
al. (p. 1040)
Various proteins are involved in the maintenance of the
intricate structures of the inner ear, and the disruption
of the genes encoding these proteins can lead to hearing
loss. Riazuddin et al. studied multiple families with a re-
cessive, moderate-to-profound hearing loss that was linked
to 5q12.3-q14.1. Their analysis of the genes in this locus
revealed pathogenic mutations in tricellulin (encoded by
TRIC), a recently identiﬁed tight-junction protein that is
expressed at the contacts between epithelial cells of body
tissues. TRIC has several splice isoforms and contains a
binding domain at its C-terminus that is similar to the C-
terminus of the structural protein occludin. Expression
analysis done on developmental sections of mouse inner
ear revealed that tricellulin concentrates at the tricellular
junctions of the cochlea and the vestibular epithelia. To
learn more about the function of tricellulin and the pos-
sible consequences of the pathogenic mutations, GST-fu-
sion proteins were produced for the wild-type protein and
one of themutants. It was predicted that, becauseoccludin
binds to the scaffolding protein ZO-1, tricellulin might
similarly interact with ZO-1 through its C-terminus–bind-
ing domain. The authors demonstrate that wild-type tri-
cellulin does bind to ZO-1 and that one of the mutations
causing hearing loss signiﬁcantly reduces the interaction.
HLA and Genomewide Allele Sharing in DZ Twins,
by Montgomery et al. (p. 1052)
There is evidence that genetic factors inﬂuencing embryo
survival can lead to a higher amount of allele sharing be-
tween siblings than would be expected randomly. Because
of the careful conditions that must be met for human
conceptions to reach full term, it is thought that those
embryos that do survive have a selective advantage over
those that do not. There are also additional conﬂicting
data regarding whether DZ twins are even more related
than regular siblings; the hypothesis is that the survival
of two twins might be more difﬁcult than the survival of
a singleton pregnancy. This potential oversharing of chro-
mosomal material becomes an issue in genetics studies,
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because DZ twins are usually treated as normal sib pairs,
with traditional assumptions about the sharing of alleles
identical by descent. If DZ twins are more closely related
than normal siblings, twin-study designs would need to be
signiﬁcantly restructured. Here, Montgomery et al. looked
at the amount of allele sharing at various loci in three
twin data sets and found no evidence of skewing of allele
transmission. These results support the customary use of
DZ twins in linkage studies.
Human Adaptive Evolution at Myostatin, by
Saunders et al. (p. 1089)
Because of the possible importance of muscle growth and
development in species survival, it is predicted that genes
involved in these processes are targets of evolutionary se-
lection. Saunders et al. examined the gene sequence of
myostatin (GDF8), an inhibitor of muscle growth, to see
whether any evidence of positive selection exists. Sequenc-
ing of the gene in African American and European indi-
viduals revealed ﬁve nonsynonymous SNPs and three syn-
onymous changes. The higher number of nonsynonymous
alterations suggested that the human variation in GDF8
was due to positive natural selection, so further com-
parisons were made in other species, and the human ratio
was indeed unusual. The authors then focused their anal-
ysis on two of the nonsynonymous SNPs, to gain more
insight into the pattern of evolution of the gene, and de-
termined that the selection in the region is relatively re-
cent and that the frequency of the polymorphisms has
increased quickly. Although the functional consequences
of the two variants are not clear, the strong observed sig-
nature of selection suggests that the changes were import-
ant in the evolutionary history of GDF8.
This Month on the Cover
In 1964, Philip Leder and Marshall Nirenberg employed
a simple binding assay to begin their quest to crack the
genetic code (Proc Nat Acad Sci USA 52:420–427). Their
method involved evaluating which di-, tri-, or polynucleo-
tides would cause binding between tRNA molecules and
ribosomes. The cover ﬁgure shows that the trinucleotide
GpUpU and poly UG induces binding of Val tRNA to ribo-
somes. Further work showed that, whereas poly UG could
direct Phe- and Val-tRNA binding, GpUpU was very spe-
ciﬁc for valine and did not induce binding to any of 17
other amino acids. Additionally, dinucleotides were una-
ble to stimulate binding, so it was determined that code
for amino acids was triplet in nature. Other trinucleotides,
including the isomers UpUpG and UpGpU, were unable
to stimulate binding to valine. This led to the conclusion
that it was speciﬁcally the sequence GUU that encoded
for the amino acid valine. With use of this technique, the
rest of the code was eventually revealed. Special thanks
to the authors—Philip Leder and Marshall Nirenberg—for
the use of their ﬁgure.
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